Cargando…
Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer’s Disease in Rat Model
INTRODUCTION: Donepezil (DPL), a specific acetylcholinesterase inhibitor, is used as a first-line treatment to improve cognitive deficits in Alzheimer’s disease (AD) and it might have a disease modifying effect. Astaxanthin (AST) is a natural potent antioxidant with neuroprotective, anti-amyloidogen...
Autores principales: | Shehata, Mustafa K, Ismail, Assem A, Kamel, Maher A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391537/ https://www.ncbi.nlm.nih.gov/pubmed/37534058 http://dx.doi.org/10.2147/IJN.S417928 |
Ejemplares similares
-
Nose to Brain Delivery of Astaxanthin–Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer’s Disease: Preparation, in vitro and in vivo Evaluation
por: Shehata, Mustafa K, et al.
Publicado: (2023) -
Astaxanthin-Loaded Nanostructured Lipid Carriers for Preservation of Antioxidant Activity
por: Rodriguez-Ruiz, Violeta, et al.
Publicado: (2018) -
Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery
por: Lin, Yin-Ku, et al.
Publicado: (2010) -
Effect of nanostructured lipid carriers on transdermal delivery of tenoxicam
in irradiated rats
por: Bawazeer, Saud, et al.
Publicado: (2020) -
Nanostructured lipid carriers: versatile oral delivery vehicle
por: Poonia, Neelam, et al.
Publicado: (2016)